Status:
RECRUITING
Asthma Symptom Perception Study
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Collaborating Sponsors:
Albert Einstein College of Medicine
Yeshiva University
Conditions:
Asthma
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
Asthma affects 8% of the United States population ages \>60 years and causes considerable harm: older adults are 4 times more likely to die from asthma and have twice the risk of hospitalization. The ...
Eligibility Criteria
Inclusion
- Age \> 60 years
- English or Spanish speaking
- Self-report or physician diagnosis of asthma \>1 year ago
- Uncontrolled asthma
Exclusion
- Dementia
- Chronic obstructive pulmonary disease (COPD), or other chronic respiratory illnesses,
- Congestive Heart Failure (CHF, New York Heart Association \[NYHA\] stages 4-5)
- Cigarette smoking \>15 packs-years
Key Trial Info
Start Date :
September 18 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 22 2028
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06612294
Start Date
September 18 2024
End Date
December 22 2028
Last Update
August 26 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Ichan School of Medicine at Mount Sinai
New York, New York, United States, 10029
2
Albert Einstein College of Medicine
The Bronx, New York, United States, 10461